Table 1.
Baseline characteristics
| Characteristic | Value |
|---|---|
| Median Age (Range) | 52 Years (18-75) |
| Sex | Male: 120 (68.57%) |
| Female: 55 (31.42%) | |
| Mean Serum Creatinine (SD) | 3.34 (2.812) mg/dl |
| Mean eGFR (SD) | 30.71 (16.06) ml/min/1.73 m2 |
| Stage of Renal Disease[%(n)] | |
| Stage 3a | 25.14% (44/175) |
| Stage 3b | 26.28% (46/175) |
| Stage 4 | 28% (49/175) |
| Stage 5 Not on Dialysis | 20.57% (36/175) |
| Underlying Renal Disease[%(n)] | |
| Diabetes Mellitus | 26.9% (47/175) |
| Hypertension | 60% (105/175) |
| Glomerulonephritis | 1.7% (3/175) |
| Nephrolithiasis | 16% (28/175) |
| Cystic Kidney Disease | 2.3% (4/175) |
| Congenital Kidney Disease | 0% (0/175) |
| Others | 14.28% (25/175) |
| Current antihypertensive use[%(n)] Angiotensin-converting enzyme inhibitor | 1.1%(2/175) |
| Angiotensin receptor blocker | 9.1%(16/175) |
| Alpha-blocker | 0.6%(1/175) |
| Beta-blocker | 9.7%(17/175) |
| Calcium channel blocker | 33.1%(58/175) |
| Diuretic | 18.3%(32/175) |
*SD-standard deviation, n-number